Ketamine, along with other psychedelics, induces a dissociative state that enables personal growth, artistic expression, and intellectual enhancement. At sub-anesthetic doses, ketamine has shown promise in resolving serious mental health conditions such as anxiety, bipolar disorder, PTSD, and depression. Among these, ketamine is particularly effective for treatment-resistant depression, which affects a third of patients suffering from depression. Ketamine alters brain chemistry by increasing the availability of substances for internal communication. Moreover, the dissociative state induced by ketamine allows patients to see themselves from a distance, facilitating the disentanglement of disorders from identities. This unique psychological effect enhances the neuroplasticity necessary for treating mental health disorders and enables patients to confront traumas and unhelpful behavioral patterns with greater ease and objectivity.